How to buy AnPac Bio-Medical Science CoLtd (ANPC) stock

AnPac Bio-Medical Science Co., Ltd is a biotechnology business based in the US. AnPac Bio-Medical Science CoLtd shares (ANPC) are listed on the NASDAQ and all prices are listed in US Dollars. AnPac Bio-Medical Science CoLtd employs 86 staff and has a trailing 12-month revenue of around 0.00.

AnPac Bio-Medical Science CoLtd stock price (NASDAQ: ANPC)

Use our graph to track the performance of ANPC stocks over time.

AnPac Bio-Medical Science CoLtd shares at a glance

• Key figures

Information last updated 2021-07-23.

Latest market close	$4.32
52-week range	$3.15 - $9.00
50-day moving average	$4.23
200-day moving average	$5.35
Wall St. target price	$8.00
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	N/A

Buy AnPac Bio-Medical Science CoLtd shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy AnPac Bio-Medical Science CoLtd stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of AnPac Bio-Medical Science Co., Ltd by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

AnPac Bio-Medical Science CoLtd price performance over time

Historical closes compared with the close of $4.32 from 2021-05-28

1 week (2021-07-13)	N/A
1 month (2021-06-24)	10.20%
3 months (2021-04-20)	N/A
6 months (2021-01-20)	N/A

1 year (2020-07-20)	N/A
2 years (2019-07-20)	N/A
3 years (2018-07-20)	N/A
5 years (2016-07-20)	N/A

AnPac Bio-Medical Science CoLtd financials

Revenue TTM	$21.8 million
Gross profit TTM	$12.9 million
Return on assets TTM	-99.54%
Return on equity TTM	-530.19%
Profit margin	0%
Book value	$0.58
Market capitalisation	$54.4 million

TTM: trailing 12 months

Shorting AnPac Bio-Medical Science CoLtd shares

There are currently 335,370 AnPac Bio-Medical Science CoLtd shares held short by investors – that's known as AnPac Bio-Medical Science CoLtd's "short interest". This figure is 8604.1% up from 3,853 last month.

There are a few different ways that this level of interest in shorting AnPac Bio-Medical Science CoLtd shares can be evaluated.

AnPac Bio-Medical Science CoLtd's "short interest ratio" (SIR)

AnPac Bio-Medical Science CoLtd's "short interest ratio" (SIR) is the quantity of AnPac Bio-Medical Science CoLtd shares currently shorted divided by the average quantity of AnPac Bio-Medical Science CoLtd shares traded daily (recently around 2.2 million). AnPac Bio-Medical Science CoLtd's SIR currently stands at 0.15. In other words for every 100,000 AnPac Bio-Medical Science CoLtd shares traded daily on the market, roughly 150 shares are currently held short.

To gain some more context, you can compare AnPac Bio-Medical Science CoLtd's short interest ratio against those of similar companies.

• Amgen (AMGN.US): 3.8
• BeiGene (BGNE.US): 15.65
• Corcept Therapeutics Incorporated (CORT.US): 12.2

However AnPac Bio-Medical Science CoLtd's short interest can also be evaluated against the total number of AnPac Bio-Medical Science CoLtd shares, or, against the total number of tradable AnPac Bio-Medical Science CoLtd shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case AnPac Bio-Medical Science CoLtd's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 AnPac Bio-Medical Science CoLtd shares in existence, roughly 30 shares are currently held short) or 0.0541% of the tradable shares (for every 100,000 tradable AnPac Bio-Medical Science CoLtd shares, roughly 54 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against AnPac Bio-Medical Science CoLtd.

Find out more about how you can short AnPac Bio-Medical Science CoLtd stock.

AnPac Bio-Medical Science CoLtd share dividends

We're not expecting AnPac Bio-Medical Science CoLtd to pay a dividend over the next 12 months.

You may also wish to consider:

• Amgen (AMGN.US) (2.68% forward annual dividend yield)

AnPac Bio-Medical Science CoLtd overview

AnPac Bio-Medical Science Co. , Ltd. , a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests to corporations and life insurance companies in the People's Republic of China. It offers cancer differentiation analysis devices and physical checkup package services. The company was incorporated in 2010 and is headquartered in Lishui, the People's Republic of China. .

Frequently asked questions

What percentage of AnPac Bio-Medical Science CoLtd is owned by insiders or institutions?
Currently 32.216% of AnPac Bio-Medical Science CoLtd shares are held by insiders and 3.635% by institutions. How many people work for AnPac Bio-Medical Science CoLtd?
Latest data suggests 86 work at AnPac Bio-Medical Science CoLtd. When does the fiscal year end for AnPac Bio-Medical Science CoLtd?
AnPac Bio-Medical Science CoLtd's fiscal year ends in December. Where is AnPac Bio-Medical Science CoLtd based?
AnPac Bio-Medical Science CoLtd's address is: 801 Bixing Street, Lishui, China, 323006 What is AnPac Bio-Medical Science CoLtd's ISIN number?
AnPac Bio-Medical Science CoLtd's international securities identification number is: US03635R1077 What is AnPac Bio-Medical Science CoLtd's CUSIP number?
AnPac Bio-Medical Science CoLtd's Committee on Uniform Securities Identification Procedures number is: 03635R107